Blog entries by researchers or other Tourette Syndrome associations, such as the Tourette Syndrome Foundation of Canada
Updated 10/6/23: Emalex Biosciences Releases Results of 12-Month Open-Label Extension Study for Tourette Syndrome Candidate In our ongoing exploration of treatment options for suppressing tics, we’ve discussed numerous approaches, such as medications and behavioral therapies like Habit Reversal Training (HRT).… Continue Reading
For the many parents of children and adolescents with persistent tic disorder and Tourette Syndrome (TS), as well as adults with TS, the quest for treatments to increase the quality of life and reduce the severity of tics is constant… Continue Reading
School is back in full swing now and as the curriculum progresses and increases in complexity, students have more information and activity to juggle and organize. Students need to manage their schoolwork, establish and follow a routine and schedule, manage… Continue Reading
What is Asperger’s Syndrome? Asperger’s Syndrome is a developmental disorder. The name Asperger’s Syndrome has been discontinued and the symptoms of Asperger’s Syndrome are now included in a condition called Autism Spectrum Disorder (ASD). Many people still use the term… Continue Reading
For TS Awareness Month, Dr. Marc Schmidt, a professor of Neurobiology at the University of Pennsylvania, explains the genetics behind Tourettes Syndrome. Is Tourette hereditary? Continue Reading
CBIT puts teens and kids more in-control of their TS tics In our last post, we presented some exciting new prospects for medicinal treatment of tics caused by Tourette’s Syndrome (TS). Today’s topic focuses on CBIT which is a behavioral… Continue Reading
So much of the news in the past two years has been dominated by the discussion and study of COVID-19, we are happy to report on remarkable research with encouraging results in the field of Tourette Syndrome. This news is… Continue Reading
Weill Cornell Medicine is conducting a research study for Children and Adults ages 7-25 with Tourette syndrome and Chronic tic disorders. For more information please call 212-746-5930.
Study 4: Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of NBI-98854 in Pediatric Subjects with Tourette Syndrome Ages: 6-17 Investigator: Roger Kurlan, MD, Overlook Medical Center, Summit, NJ Contact: Caroline Sabatino, 908-522-5901 For more information, please visit the… Continue Reading
Study 1: Multimodal Dietary Treatment in Tourette’s Syndrome Ages: 12-17 Investigator: Roger Kurlan, MD, Overlook Medical Center, Summit, NJ Contact: Caroline Sabatino, 908-522-5901 Patients with TS age 12-17 are eligible to participate. We are testing a group of dietary supplements that… Continue Reading